HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kenneth Cole

This article was originally published in The Rose Sheet

Executive Summary

Premier designer fragrance slated to bow in fall 2002 under deal with LVMH American Designer Fragrance Division for exclusive worldwide rights to create, distribute and market Kenneth Cole fragrance and body products, firm announces March 16. LVMH's Parfums Givenchy will orchestrate global development, marketing and distribution of several Kenneth Cole fragrance lines, including men's and women's scents for all of Cole's brands: Kenneth Cole New York, Reaction Kenneth Cole and Unlisted, Parisian firm says. Parfums Givenchy President/CEO Camille McDonald will spearhead the license. LVMH American Designer Fragrance Division, created in October 1999, includes licenses for designers Michael Kors and Marc Jacobs. Michael Kors men's scent and inaugural fragrance offering from Jacobs will debut in September

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009039

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel